Healthcare & Pharmaceuticals Industry Press Releases

Published on January 19, 2021 - 13:30 GMT

Tarsus Pharmaceuticals, Inc. Appoints Bryan Wahl, MD, JD as General Counsel

IRVINE, Calif., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to discover and deliver breakthrough treatments to transform the lives of patients with common …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on January 19, 2021 - 13:30 GMT

Emerald Bioscience Launches Rebrand Including Name Change to Skye Bioscience

San Diego, Calif, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on January 19, 2021 - 13:30 GMT

Royalty Pharma Acquires Royalty Interest in Seltorexant From Minerva Neurosciences

NEW YORK and WALTHAM, Mass., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) and Minerva Neurosciences, Inc. (Nasdaq: NERV) today announced that Royalty Pharma will acquire Minerva’s royalty interest in seltorexant for an upfront …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on January 19, 2021 - 13:30 GMT

RenovaCare to Present at Noble Capital Markets Annual Investor Conference on January 19, 2021

ROSELAND, N.J., Jan. 19, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, …

Distribution channels:

Published on January 19, 2021 - 13:30 GMT

Neovasc Reducer Featured in Three Peer Reviewed Publications Supporting Reducer Therapy

VANCOUVER and MINNEAPOLIS, MN, Jan. 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq, TSX: NVCN) announced today the Neovasc Reducer™ (“Reducer”) was prominently featured in three peer reviewed European …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on January 19, 2021 - 13:15 GMT

Better Choice Company Announces Strategic Investment of $2.7 Million, Co-Lead by Insiders and Management

NEW YORK, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Better Choice Company (OTCQX: BTTR) (“Better Choice”) (the “Company”), an animal health and wellness company, today announced the closing of a $2.7 million strategic investment, which will have 50% + …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 19, 2021 - 13:05 GMT

TRACON Pharmaceuticals Announces Acceptance of the Envafolimab (KN035) NDA by the NMPA in China for Priority Review

SAN DIEGO, Jan. 19, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO- …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 19, 2021 - 13:05 GMT

InCarda Therapeutics Announces Enrollment of First U.S. Patient in Phase 2 INSTANT Trial of InRhythm™ for Treatment of Atrial ...

SAN FRANCISCO, Jan. 19, 2021 (GLOBE NEWSWIRE) -- InCarda Therapeutics, Inc. (“InCarda”), a privately-held biopharmaceutical company developing first-of-their-kind inhaled therapies for cardiovascular diseases, today announced dosing of the first U.S. …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on January 19, 2021 - 13:03 GMT

Algernon Pharmaceuticals Receives Green Light from DSMB to Conduct Phase 3 Study of Ifenprodil for COVID-19

VANCOUVER, British Columbia, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to announce that the …

Distribution channels: Healthcare & Pharmaceuticals Industry